Machine Learning to Understand the Immune-Inflammatory Pathways in Fibromyalgia

Area of Science:

• Immunology
• Rheumatology
• Neuroscience

Background:

• Fibromyalgia (FM) is a chronic condition with widespread pain and other symptoms, but its underlying causes are not fully understood.
• Immune-inflammatory pathways are increasingly suspected to play a role in FM pathophysiology.
• Key inflammatory markers like cytokines and C-reactive protein are often investigated in FM research.

Purpose of the Study:

• To investigate serum levels of interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), CXCL-8, and interleukin-10 (IL-10) in female fibromyalgia patients.
• To explore the association between these immune markers and clinical severity scores in FM.
• To determine if altered cytokine levels are independently associated with fibromyalgia.

Main Methods:

• Serum samples were analyzed from 67 female FM patients and 35 healthy women.
• Levels of IL-6, hs-CRP, CXCL-8, and IL-10 were measured.
• Fibromyalgia Severity Score, Widespread Pain Index (WPI), Symptom Severity Scale (SSS), Hospital Anxiety and Depression Scale (HADS-A), and Perceived Stress Scale (PSS-10) were assessed.
• Statistical analyses, including covariate adjustment and binary regression, were performed.

Main Results:

• Fibromyalgia patients exhibited higher clinical rating scales compared to controls.
• After adjusting for age, BMI, and comorbidities, FM patients had lower levels of IL-6, IL-10, and CXCL-8 compared to healthy controls.
• hs-CRP levels did not differ significantly between groups.
• Lowered IL-10, poorer sleep quality, reduced aerobic activity, higher anxiety, and more comorbidities were associated with FM diagnosis.
• Neural network analysis indicated sleep quality, PSS-10, HADS-A, and cytokines predicted WPI, while PSS-10, HADS-A, and IL-10 predicted SSS.

Conclusions:

• Reduced levels of IL-6 and IL-10 are independently associated with fibromyalgia in women, irrespective of confounders.
• These findings suggest that diminished IL-6 and IL-10 signaling may contribute to the pathophysiology of fibromyalgia.
• Immune dysregulation, particularly involving specific cytokine pathways, warrants further investigation in FM.